Seroprevalence and incidence of Toxoplasma gondii infection in the Legnano area of Italy

Clinical Microbiology and Infection

Volumn 14, Issue 2, 2008, Pages 186-189

  De Paschale, Massimo ^a   Agrappi, C ^a   Clerici, P ^a   Mirri, P ^a   Manco, M T ^a   Cavallari, S ^a   Vigano E F ^a  

^a Hospital of Legnano   (Italy)

Author keywords

Antibodies; Incidence; Pregnancy; Screening; Seroprevalence; Toxoplasma

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PROTOZOON ANTIBODY;

ANTIBODY DETECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; INCIDENCE; ITALY; MICROORGANISM DETECTION; PREGNANCY; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; SEROPREVALENCE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

TOXOPLASMA; TOXOPLASMA GONDII;

EID: 38049088938     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2007.01883.x     Document Type: Article

References (19)

1. Agence Nationale d'Accréditation et d'Evaluation en Santé. La surveillance biologique de la femme enceinte en bonne santéet sans antécédents pathologiques. Paris: ANAES, 1996.
2. Aspock H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis 1992; 84 (suppl): 32-37.
3. Conyn van Spoondonek MAE. Prevention of congenital toxoplasmosis in The Netherlands. Bilthoven: National Institute of Public Health and Enviromental Protection, 1991.
4. Gilbert RE, Peckham CS. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen? J Med Screen 2002; 9: 135-141.
5. Petersson K, Stray-Pedersen B, Malm G, Forsgren M, Evengard B. Seroprevalence of Toxoplasma gondii among pregnant women in Sweden. Acta Obstet Gynecol Scand 2000; 79: 824-829.
6. Diza E, Frantzidou F, Souliou E et al. Seroprevalence of Toxoplasma gondii in northern Greece during the last 20 years. Clin Microbiol Infect 2005; 11: 719-723.
7. Ades AE. Methods for estimating the incidence of primary infection in pregnancy: A reappraisal of toxoplasmosis and cytomegalovirus data. Epidemiol Infect 1992; 108: 367-375.
8. Sequela JP. Cinétique des anticorps IgA, IgG, IgM dans la toxoplasmose. Lyon Med 1982; 248: 21-23.
9. Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: Experience in a US reference laboratory. J Infect Dis 2001; 183: 1248-1253.
10. Holliman RE, Bone GP, Johnson JD. The exclusion of recent onset Toxoplasma infection in patient with prolonged IgM response by the measurement of IgA and avidity. Serodiag Immunother Infect Dis 1996; 8: 57-59.
11. Janssen RS, Satten GA, Stramer SL et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998; 280: 42-48.
12. Vezzo R, VigorèL, Goglio A et al. Sieroprevalenza per anticorpi anti- Toxoplasma gondii in 14.186 soggetti. Microbiol Med 2001; 16: 220.
13. De Leo G, Vegezzi PG, Armitano S et al. Considerazioni epidemiologiche sui risultati di una ricerca policentrica di anticorpi anti- Toxoplasma. Biochim Clin 1984; 8: 1081-1091.
14. Zotti C, Garella D, Moiraghi Ruggenini A et al. Toxoplasma gondii and pregnancy: Observations relative to epidemiology, diagnosis and prevention. Minerva Ginecol 1985; 37: 671-676.
15. Munoz Batet C, Guardia Llobet C, Juncosa Morros T et al. Toxoplasmosis and pregnancy. Multicenter study of 16,632 pregnant women in Barcelona. Med Clin (Barc) 2004; 123: 12-16.
16. Evengard B, Petersson K, Engman ML et al. Low incidence of Toxoplasma infection during pregnancy and in newborns in Sweden. Epidemiol Infect 2001; 127: 121-127.
17. Jenum P, Stray-Pedersen B, Melby KK et al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 1998; 36: 2900-2906.
18. Ancelle T, Goulet V, Tirad-Fleury V etal. La toxoplasmose chez la femme enceinte en France en 1995. Résultats d'une enquête nationale périnatale. Bull Epidemiol Hebd 1996; 51: 227-229.
19. Ricci M, Pentimalli H, Thaller R, Rava L, Di Ciommo V. Screening and prevention of congenital toxoplasmosis: An effectiveness study in a population with a high infection rate. J Matern Fetal Neonatal Med 2003; 14: 398-403.